Funder: Dept. of the Army -- USAMRAA
Due Dates: June 23, 2025 (Pre-Application) | September 8, 2025 (Full Application)
Funding Amounts: Up to $1.7M total costs per award (max 3 years); ~2 awards; total program funding $3.4M
Summary: Supports translation of preclinical burn research into products (devices, drugs, or guidelines) for use in austere, resource-limited military environments.
Key Information: Clinical trials and clinical research are not permitted; proof-of-concept and prototype required at pre-application.
Description
This opportunity, offered by the Department of Defense (DoD) through the U.S. Army Medical Research Acquisition Activity (USAMRAA), funds the development of burn-focused medical products for military use. The goal is to translate promising preclinical findings into tangible products—such as medical devices, drugs, or clinical practice guidelines—that can be applied in austere, resource-limited, distributed operational environments, especially at or near the point of injury.
Projects must address at least one of the FY25 Military Burn Research Program (MBRP) Technology/Therapeutic Development Award (TTDA) focus areas and demonstrate clear military relevance. Both tangible products and knowledge products (if directly supporting a technology or therapeutic) are eligible, provided they are at a minimum Technology Readiness Level (TRL) or Knowledge Readiness Level (KRL) of 3 at pre-application.
Clinical trials and clinical research involving human subjects are not allowed under this mechanism.
Due Dates
- Pre-Application (Preproposal) Deadline: June 23, 2025, 5:00 p.m. ET
- Invitation to Submit Full Application: July 18, 2025
- Full Application Deadline: September 8, 2025, 11:59 p.m. ET
- End of Application Verification Period: September 15, 2025, 5:00 p.m. ET
Funding Amount
- Total Program Funding: ~$3.4 million
- Expected Number of Awards: ~2
- Maximum Award Amount: $1.7 million total costs per award (direct + indirect)
- Maximum Period of Performance: 3 years
All direct and indirect costs of any subaward or contract must be included in the primary award’s direct costs. The full amount may be requested for projects of less than 3 years if justified.
Eligibility
- Eligible Organizations:
- Extramural (non-DoD) and intramural (DoD) organizations
- Academic institutions, biotechnology companies, foundations, federal agencies (except DoD for extramural), research institutes, for-profit and non-profit, public or private, domestic or foreign
- Principal Investigator (PI):
- Must be at or above Assistant Professor (or equivalent independent investigator in industry)
- No citizenship or nationality restrictions
- No limit on the number of applications per PI
- Not Eligible:
- Federally Funded Research and Development Centers (FFRDCs) cannot receive awards directly, but may participate via teaming arrangements
- Other:
- Awards are made to organizations, not individuals
- Cost sharing is not required (except for certain Other Transactions)
Application Process
Step 1: Pre-Application (Required)
- Submit via eBRAP
- Includes a 3-page narrative, references, list of abbreviations, and biosketches
- Must demonstrate proof-of-concept and a prototype/preliminary version of the product
Step 2: Full Application (By Invitation Only)
- Invited applicants submit via Grants.gov (extramural) or eBRAP (intramural DoD)
- Includes detailed project narrative (15 pages), supporting documentation, technical and lay abstracts, statement of work, impact statement, transition plan, and other required attachments
- Animal research plan required if applicable
- Budget and justification required
Note: Registration in SAM.gov, eBRAP, and Grants.gov is required and can take several weeks.
Additional Information
- Focus Areas: Projects must address at least one of the following:
- Prevention, triage, or treatment of cold injury
- Innovation in acute burn care in combat settings
- Methods to prevent, assess, or treat burn complications (e.g., fluid resuscitation, sepsis, inhalation injuries, fungal infections, hypermetabolism)
- Interventions to mitigate long-term pain, neuropathy, or temperature dysregulation after burn injury
- Readiness Level: Product must be at least TRL/KRL 3 at pre-application (proof-of-concept and prototype required)
- Clinical Trials: Not permitted; no enrollment of human subjects
- Collaborations: Multidisciplinary and cross-sector collaborations (academia, industry, military, VA) are encouraged
- Review Process: Two-tiered (peer review for technical merit, programmatic review for relevance and impact)
- Reporting: Annual and final technical progress reports required
External Links
Contact Information